NCT03658460View on ClinicalTrials.gov

Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 22, 2018

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Non-small-cell Lung CancerCarcinoma, Non-Small-Cell LungLung Neoplasm
Interventions
OTHER

DNA sequencing

Targeted next generation sequencing and gene expression analysis with focus on immuno-oncology signatures

Trial Locations (1)

9000

Dept. of Oncology, Aalborg University Hospital, Aalborg

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

lead

Aalborg University Hospital

OTHER

NCT03658460 - Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers | Biotech Hunter | Biotech Hunter